Long-term partners who share our vision of transforming exosome science into clinically meaningful therapies.
P.S.K Biosciences is a platform-driven biotechnology company focused on advancing engineered exosome delivery technologies and natural exosome-based innovative medicines. We welcome long-term investors and strategic partners who share our vision of building a next-generation exosome therapeutics platform.
We are honored to have the support of leading pharmaceutical companies and venture capital partners.
A leading Chinese investment holding company with deep roots in healthcare and technology innovation.
One of China's leading pharmaceutical companies with strong R&D capabilities and a global commercialization network.
Long-term venture capital partners supporting our platform development and clinical translation.
We welcome long-term investors and strategic partners who share our vision.
Contact Our BD Team